Log In
Print this Print this

anti-Mucin1 (MUC1) CAR-pNK cells

  Manage Alerts
Collapse Summary General Information
Company PersonGen Biomedicine (Suzhou) Co. Ltd.
DescriptionAnti-Mucin1 (MUC1) CAR-pNK cells
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat MUC1 positive relapsed or refractory solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today